Immunovation TX
Immunotherapy biotech developing targeted cancer treatments
Company Overview
Snapshot
Founded in November 2025, Immunovation TX is an Israeli biotech startup operating with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of novel immunotherapy-based treatments for cancer.
Business overview
Immunovation TX is an Israeli biotech startup dedicated to developing novel immunotherapy-based treatments for cancer. The company's core technology leverages the immune system to selectively target and destroy tumor cells while minimizing damage to healthy tissue. Its research and development efforts are centered on proprietary therapeutic platforms and drug candidates designed to improve the efficacy, safety, and durability of response compared to existing oncology treatments. Immunovation TX operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development, aiming to address unmet medical needs in oncology and improve patient outcomes.
Log in to access full profile ›Company Intelligence Q&A
- What is Immunovation TX's primary focus?
- Immunovation TX is an Israeli biotech startup focused on developing novel immunotherapy-based treatments for cancer, leveraging the immune system to selectively target tumor cells.
- When was Immunovation TX founded?
- Immunovation TX was founded in November 2025.
- What stage is Immunovation TX currently in?
- Immunovation TX is currently in the Pre-Funding stage.
- What is Immunovation TX's employee count?
- Immunovation TX operates with 1–10 employees.
- What is the company's approach to cancer treatment?
- Immunovation TX's approach involves developing proprietary therapeutic platforms and drug candidates that utilize the immune system to target and destroy tumor cells, aiming for improved efficacy and safety in oncology treatments.